Aurobindo Pharma plans capexIllustrative image – not actual.

Aurobindo Pharma (APL) has chalked out an investment plan of Rs 1,250 crore to be implemented by 2015.

APL is likely to have a cash flow of Rs 800 crore. Of this, Rs 250 crore will be utilised for capital expenditure and Rs 150 crore towards working capital margin. The remaining Rs 400 crore will be free cash flow to be utilised for funding the redemptions (if any) of foreign currency convertible bonds over the next two years.

At present, APL is constructing a separate block for production of oral contraceptives at cost of Rs 60 crore at its facility in the SEZ near Jadcherla in Andhra Pradesh. The proposed facility is slated to be ready by June 2011.

In March 2010, APL launched AuroSource, its new Rs 100-crore division for providing custom research and manufacturing services.

← All latest storiesBack to top →